Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study of the Efficacy, Tolerability and Safety of Ketoprofen Topical Patch, 20% (KTP) in the Treatment of Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee
1 other identifier
interventional
330
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of a ketoprofen topical patch on the pain associated with tendonitis or bursitis of the shoulder, elbow or knee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Jun 2006
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 30, 2006
CompletedFirst Posted
Study publicly available on registry
July 14, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedFebruary 19, 2020
February 1, 2020
8 months
June 30, 2006
February 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Average pain intensity during daily activities
Secondary Outcomes (5)
Average pain intensity while at rest
Functional disability
Use of prn rescue medication
Quality of sleep
Patient's and physician's global assessments of study medication
Interventions
Eligibility Criteria
You may qualify if:
- Males or females 18 years of age or older
- Diagnosis of tendonitis or bursitis of the shoulder, elbow or knee
- Meet pain entry criteria
- Willing to discontinue use of any pain medication not provided by the study
You may not qualify if:
- Have tendonitis or bursitis secondary to a systemic inflammatory disease, calcification or requiring surgery
- Have received corticosteroids in the 30 days preceding screening
- Have a history or physical examination finding that is incompatible with safe participation in the study
- Have a history or physical examination finding that is incompatible with study product use
- Are taking medications or other substances contraindicated due to the nature of the study medication or the potential for drug interactions.
- Are taking medications that may significantly affect renal function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PPD
Austin, Texas, 78704, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
PPD
PPD Austin, TX
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 30, 2006
First Posted
July 14, 2006
Study Start
June 1, 2006
Primary Completion
February 1, 2007
Study Completion
March 1, 2007
Last Updated
February 19, 2020
Record last verified: 2020-02